NCT06065501Completed
Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease
Frailty Trajectories and Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease: A Longitudinal Study
Source: ClinicalTrials.gov · Last updated 26 Jun 2025
Brief summary (registry, in English)
This is a randomized controlled trial study conducted on frail patients with chronic kidney disease(CKD).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 26 Sept 2023
- Start date
- 19 Oct 2023
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- National Cheng Kung University
- Diseases
- Chronic kidney disease
- NCT number
- NCT06065501
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 19 Oct 2023 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received renal replacement therapy
Other
- Participants achieved TTM stage 5
Who the study is looking for
- Diagnosed with CKD stage 1 to 5
- Participants with pre-frail and frail conditions.
- Having access to a mobile phone and is capable of using mobile social network application (Line)
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cheng Kung University Hospital Coordinator of this site? Confirm its status | Tainan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.